Bortezomib Chinese instructions

1. Indications:

Bortezomib is mainly used to treat the following diseases:

1.Multiple Myeloma (Multiple Myeloma): This is a malignant tumor that affects the bone marrow, causing abnormal plasma cell proliferation, destroying bones and weakening the immune system.

2.Certain non-Hodgkin lymphomas (Non-Hodgkin Lymphoma): Bortezomib may be used to treat some specific non-Hodgkin lymphomas.

2. Mechanism of action:

Bortezomib's mechanism of action involves inhibition of the proteasome. Proteasomes are special structures within cells that are responsible for breaking down and degrading proteins. Cancer cells require large amounts of protein to sustain their rapid proliferation and growth, so the proteasome is critical to their survival. Bortezomib blocks the protein degradation process inside cancer cells by inhibiting the function of the proteasome, causing cancer cells to stop proliferation and eventually die.

3. Pharmacology:

The pharmacological characteristics of bortezomib include:

1.Absorption: Bortezomib is usually given to patients as an injection to ensure high bioavailability.

2.Distribution: It is widely distributed in the body, including entering the bone marrow, and directly affects multiple myeloma.

3.Metabolism: Bortezomib is metabolized in the liver and excreted by the kidneys.

4.Clearment: Its elimination half-life is relatively short, and regular treatment is required to maintain the therapeutic effect.

4. Dosage and usage:

The dosage and administration of bortezomib will vary based on the patient's specific condition and treatment regimen. Common usage includes:

1.Injection: Bortezomib is usually given to patients as an intravenous injection. The frequency and dosage of injections are determined by the doctor based on the patient's needs and efficacy.

2.Treatment cycles: Treatment with bortezomib is usually divided into cycles, with each cycle consisting of a certain number of treatment days followed by a rest period to ensure that the patient's body can adapt to the treatment.

5. Side effects:

Bortezomib may cause a range of side effects, including but not limited to: nausea and vomiting, diarrhea, fatigue, peripheral neuropathy, thrombocytopenia, leukopenia, anemia, fever, kidney function damage, cardiovascular problems, liver function damage, pulmonary toxicity, elevated blood sugar, etc.

6. Warnings and precautions:

1.Patients need to be monitored and evaluated by doctors regularly to ensure the effectiveness of treatment and to detect adverse reactions in a timely manner.

2.Adverse reactions, especially peripheral neuropathy, should receive special attention.

3.Patients should follow the doctor’s prescriptions and recommendations and should not change or discontinue treatment on their own.

4.Because bortezomib may have effects on the immune system, patients should take steps to reduce the risk of infection, such as avoiding contact with infected patients and maintaining good hygiene.

7. Contraindications:

Bortezomib has some contraindications, including patients with allergies to the drug and patients with serious heart problems or known allergies to bortezomib.

8. Drug interactions:

Patients should tell their doctors about other medications they are taking, including prescription drugs, over-the-counter drugs, and supplements. Bortezomib may interact with other medications, so doctors need to know this information.

9. Medicine for special groups:

For certain patient groups, such as pregnant women, lactating women, children, and elderly patients, the dosing of bortezomib may require special attention and adjustments. In these cases, treatment needs to be individualized based on the patient's age, gender, and physiological status.

10. Listing and price situation:

Bortezomib is already on the market in China and has been included in medical insurance. Patients can purchase it domestically at a price of around 3,000 to 4,000 yuan. Please consult the local hospital pharmacy for specific prices and reimbursement policies. The cheaper ones abroad are mainly Indian generic drugs, which cost around 1,000 yuan and have basically the same ingredients as the domestic bortezomib drug.

In summary, bortezomib is an important anticancer drug, especially playing a key role in the treatment of multiple myeloma. However, patients should closely follow their doctor's advice when receiving treatment and undergo regular monitoring and evaluation to ensure the safety and effectiveness of the treatment while minimizing the impact of side effects.